Smart Cells launches social campaign to support Rare Disease Day 2018

There are more than 6000 known rare diseases and over 30 million people living daily with them. 28th February marks Rare Disease Day 2018, a date that highlights awareness around these conditions and the need for more research into them. Private cord blood company, Smart Cells, has chosen to support Rare Disease Day this year by running a social media campaign across their platforms.

If you’re living with a rare disease, which is defined by the European Union as one which affects less than 1 in 2000 people, you might feel alone with your condition. Treatments and cures can be few and far between; misdiagnoses and delayed treatment for rare diseases are common. This is due to the rarity of the conditions meaning that the opportunity to research them is so small, and scientific knowledge surrounding them is lacking.

The theme for this year’s Rare Disease Day is research and patient participation. Encouraging healthcare professionals, policymakers and researchers to seize the opportunity for research with current patients can make a world of difference to developments for those being diagnosed or treated currently and in the future.

This is why Smart Cells have chosen to show their support for Rare Disease Day 2018. Thanks to occasions like this, awareness has increased significantly. The first Rare Disease Day events took place in 2008 in just 18 countries; in 2017, 94 countries participated. Several conditions that Smart Cells’ audience live with can be categorised as rare diseases, and so their campaign aims to increase their awareness of what is being done to support them as well as encouraging them to participate in research that could potentially help future patients with these conditions.

Smart Cells’ social media campaign aims to cover the following four bases:

·         What is Rare Disease Day?

·         What can you do to help for Rare Disease Day?

·         What is a rare disease?

·         Two examples of rare diseases: Thalassemia Major and Severe Combined Immunodeficiency.

The imagery will be shared on Smart Cells’ blog and social media accounts – Facebook, Twitter and Instagram – in the run up to Rare Disease Day 2018 and on the day itself.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Smart Cells International Ltd. (2019, June 20). Smart Cells launches social campaign to support Rare Disease Day 2018. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20180223/Smart-Cells-launches-social-campaign-to-support-Rare-Disease-Day-2018.aspx.

  • MLA

    Smart Cells International Ltd. "Smart Cells launches social campaign to support Rare Disease Day 2018". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20180223/Smart-Cells-launches-social-campaign-to-support-Rare-Disease-Day-2018.aspx>.

  • Chicago

    Smart Cells International Ltd. "Smart Cells launches social campaign to support Rare Disease Day 2018". News-Medical. https://www.news-medical.net/news/20180223/Smart-Cells-launches-social-campaign-to-support-Rare-Disease-Day-2018.aspx. (accessed November 24, 2024).

  • Harvard

    Smart Cells International Ltd. 2019. Smart Cells launches social campaign to support Rare Disease Day 2018. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20180223/Smart-Cells-launches-social-campaign-to-support-Rare-Disease-Day-2018.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.